673 related articles for article (PubMed ID: 35254121)
41. Performance of the FREND™ COVID-19 IgG/IgM Duo point-of-care test for SARS-CoV-2 antibody detection.
De Munck DG; Peeters B; Huyghe E; Goossens H; Ieven M; Matheeussen V
Acta Clin Belg; 2022 Jun; 77(3):647-652. PubMed ID: 34152943
[TBL] [Abstract][Full Text] [Related]
42. Neutralizing activity to SARS-CoV-2 in 1.2 to 10.0 month convalescent plasma samples of COVID-19: A transversal surrogate in vitro study performed in Quito-Ecuador.
Villacrés-Granda B; Paz E; Burbano MJ; Villacrés-Granda I; Armijos D; Aguirre M
J Med Virol; 2022 Sep; 94(9):4246-4252. PubMed ID: 35585654
[TBL] [Abstract][Full Text] [Related]
43. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
Front Public Health; 2020; 8():620222. PubMed ID: 33681115
[No Abstract] [Full Text] [Related]
44. Analytical and Clinical Performance of Two Point of Care Rapid Antibody Assays for SARS-CoV-2.
Chakraborty B; Nath S; Deb S; Baruah A; Paul M; Dutta SS; Barbhuiya MA
Ann Clin Lab Sci; 2023 May; 53(3):353-359. PubMed ID: 37437941
[TBL] [Abstract][Full Text] [Related]
45. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
Front Immunol; 2022; 13():827306. PubMed ID: 35173736
[TBL] [Abstract][Full Text] [Related]
46. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of a rapid semiquantitative lateral flow assay for the prediction of serum neutralizing activity against SARS-CoV-2 variants.
Hirabidian M; Bocket L; Demaret J; Vuotto F; Rabat A; Faure K; Labalette M; Hober D; Lefevre G; Alidjinou EK
J Clin Virol; 2022 Oct; 155():105268. PubMed ID: 35998394
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
[TBL] [Abstract][Full Text] [Related]
49. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
[TBL] [Abstract][Full Text] [Related]
50. Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests.
Péré H; Mboumba Bouassa RS; Tonen-Wolyec S; Podglajen I; Veyer D; Bélec L
J Virol Methods; 2021 Apr; 290():114067. PubMed ID: 33476707
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.
Nicholson S; Karapanagiotidis T; Khvorov A; Douros C; Mordant F; Bond K; Druce J; Williamson DA; Purcell D; Lewin SR; Sullivan S; Subbarao K; Catton M
Open Forum Infect Dis; 2021 Jul; 8(7):ofab239. PubMed ID: 34258311
[TBL] [Abstract][Full Text] [Related]
52. Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects.
Gillot C; Favresse J; Maloteau V; Dogné JM; Douxfils J
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835135
[TBL] [Abstract][Full Text] [Related]
53. Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.
Montesinos I; Dahma H; Wolff F; Dauby N; Delaunoy S; Wuyts M; Detemmerman C; Duterme C; Vandenberg O; Martin C; Hallin M
J Clin Virol; 2021 Nov; 144():104988. PubMed ID: 34607239
[TBL] [Abstract][Full Text] [Related]
54. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
Meschi S; Colavita F; Bordi L; Matusali G; Lapa D; Amendola A; Vairo F; Ippolito G; Capobianchi MR; Castilletti C;
J Clin Virol; 2020 Aug; 129():104539. PubMed ID: 32679298
[TBL] [Abstract][Full Text] [Related]
55. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.
Mazzini L; Martinuzzi D; Hyseni I; Benincasa L; Molesti E; Casa E; Lapini G; Piu P; Trombetta CM; Marchi S; Razzano I; Manenti A; Montomoli E
J Immunol Methods; 2021 Feb; 489():112937. PubMed ID: 33253698
[TBL] [Abstract][Full Text] [Related]
56. Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
Wang K; Long QX; Deng HJ; Hu J; Gao QZ; Zhang GJ; He CL; Huang LY; Hu JL; Chen J; Tang N; Huang AL
Clin Infect Dis; 2021 Aug; 73(3):e531-e539. PubMed ID: 32745196
[TBL] [Abstract][Full Text] [Related]
57. Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing antibodies.
Wang JJ; Zhang N; Richardson SA; Wu JV
Expert Rev Mol Diagn; 2021 Apr; 21(4):363-370. PubMed ID: 33840347
[No Abstract] [Full Text] [Related]
58. Assessment of dengue and COVID-19 antibody rapid diagnostic tests cross-reactivity in Indonesia.
Santoso MS; Masyeni S; Haryanto S; Yohan B; Hibberd ML; Sasmono RT
Virol J; 2021 Mar; 18(1):54. PubMed ID: 33706767
[TBL] [Abstract][Full Text] [Related]
59. Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.
Chansaenroj J; Yorsaeng R; Puenpa J; Wanlapakorn N; Chirathaworn C; Sudhinaraset N; Sripramote M; Chalongviriyalert P; Jirajariyavej S; Kiatpanabhikul P; Saiyarin J; Soudon C; Thienfaidee O; Ayuthaya TPN; Brukesawan C; Intharasongkroh D; Chaiwanichsiri D; Issarasongkhram M; Kitphati R; Mungaomklang A; Thitithanyanont A; Nagavajara P; Poovorawan Y
PLoS One; 2022; 17(4):e0267102. PubMed ID: 35446889
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
